OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
Wei Cao, Hongda Chen, Yiwen Yu, et al.
Chinese Medical Journal (2021) Vol. 134, Iss. 7, pp. 783-791
Open Access | Times Cited: 2127

Showing 1-25 of 2127 citing articles:

Cancer statistics in China and United States, 2022: profiles, trends, and determinants
Changfa Xia, Xuesi Dong, Li He, et al.
Chinese Medical Journal (2022) Vol. 135, Iss. 5, pp. 584-590
Open Access | Times Cited: 2555

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
Feng‐Hua Wang, Xiao‐Tian Zhang, Yuanfang Li, et al.
Cancer Communications (2021) Vol. 41, Iss. 8, pp. 747-795
Open Access | Times Cited: 485

The path to healthy ageing in China: a Peking University–Lancet Commission
Xinxin Chen, John Giles, Yao Yao, et al.
The Lancet (2022) Vol. 400, Iss. 10367, pp. 1967-2006
Open Access | Times Cited: 370

Non‐small cell lung cancer in China
Peixin Chen, Yunhuan Liu, Yaokai Wen, et al.
Cancer Communications (2022) Vol. 42, Iss. 10, pp. 937-970
Open Access | Times Cited: 345

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial
Zixian Wang, Chengxu Cui, Jun Yao, et al.
Cancer Cell (2022) Vol. 40, Iss. 3, pp. 277-288.e3
Open Access | Times Cited: 314

National and subnational trends in cancer burden in China, 2005–20: an analysis of national mortality surveillance data
Jinlei Qi, Menglong Li, Lijun Wang, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 12, pp. e943-e955
Open Access | Times Cited: 214

Esophageal cancer: Epidemiology, risk factors and screening
Li Jiang, Jianguo Xu, Yadi Zheng, et al.
Chinese Journal of Cancer Research (2021) Vol. 33, Iss. 5, pp. 535-547
Open Access | Times Cited: 125

Global burden and trends of lung cancer incidence and mortality
Chao Li, Shaoyuan Lei, Li Ding, et al.
Chinese Medical Journal (2023)
Open Access | Times Cited: 117

Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion
Wanjia Tian, Ningjing Lei, Junying Zhou, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 93

The pyroptotic role of Caspase-3/GSDME signalling pathway among various cancer: A Review
Asif Ahmad Bhat, Riya Thapa, Obaid Afzal, et al.
International Journal of Biological Macromolecules (2023) Vol. 242, pp. 124832-124832
Closed Access | Times Cited: 93

Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors
Shazia Sofi, Umar Mehraj, Hina Qayoom, et al.
Medical Oncology (2022) Vol. 39, Iss. 9
Open Access | Times Cited: 88

Cancer profiles in China and comparisons with the USA: a comprehensive analysis in the incidence, mortality, survival, staging, and attribution to risk factors
Siyi He, Changfa Xia, He Li, et al.
Science China Life Sciences (2023) Vol. 67, Iss. 1, pp. 122-131
Closed Access | Times Cited: 83

Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma
Deniz Tümen, Philipp Heumann, Karsten Gülow, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3202-3202
Open Access | Times Cited: 78

Overview and countermeasures of cancer burden in China
Yian Wang, Qijia Yan, Chunmei Fan, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 11, pp. 2515-2526
Open Access | Times Cited: 78

Viral vectors and extracellular vesicles: innate delivery systems utilized in CRISPR/Cas-mediated cancer therapy
Seyed Esmaeil Ahmadi, Maral Soleymani, Fahimeh Shahriyary, et al.
Cancer Gene Therapy (2023) Vol. 30, Iss. 7, pp. 936-954
Open Access | Times Cited: 50

Ferroptosis in lung cancer: a novel pathway regulating cell death and a promising target for drug therapy
Nan Xing, Qinyun Du, Sa Guo, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 47

miR-509–5p promotes colorectal cancer cell ferroptosis by targeting SLC7A11
Mahmoud A. Elrebehy, Tamer M. Abdelghany, Mostafa M. Elshafey, et al.
Pathology - Research and Practice (2023) Vol. 247, pp. 154557-154557
Closed Access | Times Cited: 46

Neoadjuvant sintilimab and chemotherapy in patients with potentially resectable esophageal squamous cell carcinoma (KEEP-G 03): an open-label, single-arm, phase 2 trial
Xiaofeng Chen, Xiang Xu, Danping Wang, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 2, pp. e005830-e005830
Open Access | Times Cited: 45

Incidence, mortality, survival, and disease burden of breast cancer in China compared to other developed countries
Xuetong Tao, Tong Li, Ziba Gandomkar, et al.
Asia-Pacific Journal of Clinical Oncology (2023) Vol. 19, Iss. 6, pp. 645-654
Open Access | Times Cited: 43

Different Targeting Ligands-Mediated Drug Delivery Systems for Tumor Therapy
Shuxin Yan, Jintong Na, Xiyu Liu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 248-248
Open Access | Times Cited: 31

Cannabidiol activates MAPK pathway to induce apoptosis, paraptosis, and autophagy in colorectal cancer cells
Na Young Kim, Chakrabhavi Dhananjaya Mohan, Gautam Sethi, et al.
Journal of Cellular Biochemistry (2024) Vol. 125, Iss. 4
Closed Access | Times Cited: 20

Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy
Deepak Chandra Joshi, Anurag Sharma, Sonima Prasad, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 19

The roles of epigallocatechin gallate in the tumor microenvironment, metabolic reprogramming, and immunotherapy
Dongming Li, Donghui Cao, Yuanlin Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 15

Epigenetic Alteration in Colorectal Cancer: Potential Diagnostic and Prognostic Implications
Qing Cao, Ye Tian, Ziyin Deng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3358-3358
Open Access | Times Cited: 15

Page 1 - Next Page

Scroll to top